Marex Group CEO Ian T. Lowitt sells 16.2K shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Marex Group Ltd Chief Executive Officer Ian T. Lowitt sold 16,232 ordinary shares on November 17, 2026, in five reported transactions. The sales were effected under a Rule 10b5-1 plan entered into on August 15, 2026.
Insider Trade Summary 10b5-1
Net Seller: 16,232 shares
Net Sell
5 txns
Insider
Lowitt Ian T
Role
Chief Executive Officer
Sold
16,232 shs ($1.10M)
Share of Position Sold
0.57%
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Ordinary Shares F1, F2 | 4,962 | $66.6369 | $331K |
| Sale | Ordinary Shares F1, F3 | 5,313 | $67.7135 | $360K |
| Sale | Ordinary Shares F1, F4 | 4,004 | $68.5316 | $274K |
| Sale | Ordinary Shares F1, F5 | 1,853 | $69.6809 | $129K |
| Sale | Ordinary Shares F1, F6 | 100 | $70.39 | $7K |
Holdings After Transaction:
Ordinary Shares — 2,819,240 shares (Direct)
Holdings Before and After:
Ordinary Shares, 2,835,472 to 2,819,240 shares (Direct)
Other Insiders: 2 other insiders reported open-market sales of this stock in the 30 days up to this filing.
Footnotes (6)
- F1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 plan entered into by the Reporting Person on August 15, 2026.
- F2. The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $66.14 to $67.12, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F3. The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $67.20 to $68.13, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F4. The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $68.145 to $69.08, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F5. The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $69.212 to $70.12, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F6. The number of ordinary shares reported herein includes 194,411 shares underlying deferred bonus plan awards previously granted to the Reporting Person. Each award represents a contingent right to receive one (1) ordinary share of the Issuer upon vesting and settlement of the applicable award.
Key Figures
Ordinary shares sold: 16,232 shares
Weighted-average price for 4,962-share transaction: $66.6369 per share
Weighted-average price for 5,313-share transaction: $67.7135 per share
+3 more
6 metrics
Ordinary shares sold
16,232 shares
Five transactions on November 17, 2026
Weighted-average price for 4,962-share transaction
$66.6369 per share
November 17, 2026
Weighted-average price for 5,313-share transaction
$67.7135 per share
November 17, 2026
Weighted-average price for 4,004-share transaction
$68.5316 per share
November 17, 2026
Weighted-average price for 1,853-share transaction
$69.6809 per share
November 17, 2026
Reported price for 100-share transaction
$70.3900 per share
November 17, 2026
Key Terms
Rule 10b5-1 plan, weighted average price
2 terms
Rule 10b5-1 plan regulatory
"sales were effected pursuant to a Rule 10b5-1 plan"
A Rule 10b5-1 plan is a prearranged, written schedule that lets corporate insiders buy or sell company stock at set times or amounts, even if they later learn material nonpublic information. Think of it like setting an automatic thermostat for trades: it creates a clear record that trades were planned in advance, reducing the risk of insider-trading accusations and helping investors trust that insider transactions are routine rather than based on secret information.
weighted average price financial
"The price reported in Column 4 is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What prices did MRX CEO Ian T. Lowitt report for the November 17 sale?
The five reported per-share prices were $66.6369, $67.7135, $68.5316, $69.6809 and $70.3900. The first four were identified as weighted-average prices; the fifth transaction covered 100 shares.
AI-generated analysis. How Rhea-AI works. Not financial advice.